BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 8,870.00
+50.00 (0.57%)
At close: Sep 3, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 78.26 billion as of September 4, 2026. Its market cap has decreased by -50.90% in one year.
Market Cap
78.26B
Enterprise Value
23.01B
Revenue
19.53B
Ranking
n/a
PE Ratio
12.00
Stock Price
8,870.00
ChartMarket Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 78.26B, a decrease of -59.46%. That is a compound annual growth rate of -18.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 77.13B | -43.86% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 97.59B |
| Choong Ang Vaccine Laboratory | 86.37B |
| EyeGene | 83.26B |
| SunBio,Inc. | 75.48B |
| CTCBIO | 74.48B |
| IMGT Co.,Ltd. | 71.33B |
| AriBioLab | 70.60B |
| Psomagen | 69.15B |